Irreproducible and uninterpretable polymyxin B MICs for enterobacter cloacae and enterobacter aerogenes

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4106-4111

  Landman, David ^a   Salamera, Julius ^a,b   Quale, John ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Trinitas Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CIPROFLOXACIN; GENTAMICIN; MEROPENEM; POLYMYXIN B; TIGECYCLINE;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; EPSILOMETER TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

ANTI-BACTERIAL AGENTS; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B; REPRODUCIBILITY OF RESULTS;

EID: 84889839494     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02129-13     Document Type: Article

References (33)

1. Fridkin SK. 2001. Increasing prevalence of antimicrobial resistance in intensive care units. Crit. Care Med. 29:N64-N68.
2. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. 2011. Early dissemination of NDM-1-and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob. Agents Chemother. 55:1274-1278.
3. Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y. 2008. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob. Agents Chemother. 52:1413-1418.
4. Landman D, Bratu S, Kochar S, Panwar M, Trehan M, Doymaz M, Quale J. 2007. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae in Brooklyn, NY. J. Antimicrob. Chemother. 60:78-82.
5. Gales AC, Reis AO, Jones RN. 2001. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39:183-190.
6. Hindler JA, Humphries RM. 2013. Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. J. Clin. Microbiol. 51:1678-1684.
7. Tan TY, Ng SY. 2007. Comparison of Etest, Vitek, and agar dilution for susceptibility testing of colistin. Clin. Microbiol. Infect. 13:541-544.
8. Turnidge JD, Bell JM, Jones RN. 2007. Emergence of colistin-resistant Klebsiella spp. and Enterobacter spp. in the Asia-Pacific (APAC) region: a SENTRY antimicrobial surveillance program report (2006), abstr C2-2054. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
9. Karvanen M, Malmber C, Moamed A, Lagerback P, Friberg LE, Cars O. 2011. Colistin is extensively lost during normal experimental conditions, abstr D-690. Abstr. 51st Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
10. Bliss EA, Chandler CA, Schoenbach EB. 1949. In vitro studies of polymyxin. Ann. N. Y. Acad. Sci. 51:944-951.
11. Traub WH. 1982. Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B. Chemotherapy 28:363-368.
12. Schurek KN, Sampaio JLM, Kiffer CRV, Sinto S, Mendes CMF, Hancock REW. 2009. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:4345-4351.
13. Hawley JS, Murray CK, Griffith ME, McElmeel ML, Fulcher LC, Hospenthal DR, Jorgensen JH. 2007. Susceptibility of Acinetobacter strains isolated from deployed U.S. military personnel. Antimicrob. Agents Chemother. 51:376-378.
14. Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L. 2006. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:2946-2950.
15. Lo-Ten-Foe JR, de Smet AMGA, Diederen BMW, Kluytmans JAJW, van Keulen PHJ. 2007. Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob. Agents Chemother. 51:3726-3730.
16. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 9th ed, vol 32, no. 2. Approved standard M7-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
17. Landman D, Butnariu M, Bratu S, Quale J. 2009. Genetic relatedness of multidrug-resistant Acinetobacter baumannii endemic to New York City. Epidemiol. Infect. 137:174-180.
18. Fernandez L, Gooderham WJ, Bains M, McPhee JB, Wiegand I, Hancock REW. 2010. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two component regulatory system ParR-ParS. Antimicrob. Agents Chemother. 54:3372-3382.
19. Macfarlane ELA, Kwasnicka A, Ochs MM, Hancock REW. 1999. PhoPPhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol. Microbiol. 34:305-316.
20. Gutu AD, Sgambati N, Strasbourger P, Brannon MK, Jacobs MA, Haugen E, Kaul RK, Johansen HK, Hoiby N, Moskowitz SM. 2013. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems. Antimicrob. Agents Chemother. 57:2204-2215.
21. Miller AK, Brannon MK, Stevens L, Johansen HK, Selgrade SE, Miller SI, Hoiby N, Moskowitz SM. 2011. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob. Agents Chemother. 55:5761-5769.
22. McPhee JB, Lewenza S, Hancock RE. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50:205-217.
23. Moskowitz SM, Ernst RK, Miller SI. 2004. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186:575-579.
24. Barrow K, Kwon DH. 2009. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:5150-5154.
25. Fernandez L, Jenssen H, Bains M, Wiegand I, Gooderham WJ, Hancock REW. 2012. The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS. Antimicrob. Agents Chemother. 56:6212-6222.
26. Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, Bonomo RA. 2009. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 53:3628-3634.
27. Arroyo LA, Herrera CM, Fernandez L, Hankins JV, Trent MS, Hancock REW. 2011. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob. Agents Chemother. 55: 3743-3751.
28. Moffatt JH, Harper M, Adler B, Nation RL, Li J, Boyce JD. 2011. Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55:3022-3024.
29. Moffatt JH, Harper M, Harrison P, Hale JDF, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, Adler B, Nation RL, Li J, Boyce JD. 2010. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54:4971-4977.
30. Helander IM, Kato Y, Kilpelainen I, Kostianen R, Lindner B, Nummila K, Sugiyama T, Yokochi T. 1996. Characterization of lipopolysaccharides of polymyxin-resistant and polymyxin-sensitive Klebsiella pneumoniae O3. Eur. J. Biochem. 237:272-278.
31. Nummila K, Kilpelainen I, Zahringer U, Vaara M, Helander IM. 1995. Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-amino-ethyl pyrophosphate and contain aminoarabinose in lipid A. Mol. Microbiol. 16:271-278.
32. Peterson AA, Fesik SW, McGroarty EJ. 1987. Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium. Antimicrob. Agents Chemother. 31:230-237.
33. Gunn JS. 2008. The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol. 16:284-290.